2nd Quarter - Termination
RICCHETTI INCORPORATED for EAGLE PHARMACEUTICALS, INC.
Client
Income
$40,000
Expenses
—
Terminated
Jun 1, 2021
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Reimbursement policies for 505(b)(2) approved drugs; Drug pricing and Medicare and Medicaid reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Pharmacy PHA
Issues related to pharmaceutical industry, generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.